Tejido adiposo como diana terapéutica en la obesidad

Haffner, 2006, Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials, J Cardiovasc Pharmacol, 47, 469, 10.1097/01.fjc.0000211729.30927.4d Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer, 4, 579, 10.1038/nrc1408 Savage, 2003, Human metabolic syndrome resulting from dominantnegative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma, Diabetes, 52, 910, 10.2337/diabetes.52.4.910 Barroso, 1999, Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature, 402, 880, 10.1038/47254 Karelis, 2004, Can we identify metabolically healthy but obese individuals (MHO)?, Diabetes Metab, 30, 569, 10.1016/S1262-3636(07)70156-8 Karelis, 2005, The metabolically healthy but obese individual presents a favorable inflammation profile, J Clin Endocrinol Metab, 90, 4145, 10.1210/jc.2005-0482 Sims, 2001, Are there persons who are obese, but metabolically healthy?, Metabolism, 50, 1499, 10.1053/meta.2001.27213 Dandona, 2004, Inflammation: the link between insulin resistance, obesity and diabetes, Trends Immunol, 25, 4, 10.1016/j.it.2003.10.013 Wellen, 2005, Inflammation, stress, and diabetes, J Clin Invest, 115, 1111, 10.1172/JCI200525102 Kraegen, 2001, The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity, Exp Clin Endocrinol Diabetes, 109, S189, 10.1055/s-2001-18581 Lelliott, 2004, Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation, Int J Obes Relat Metab Disord, 28, S22, 10.1038/sj.ijo.0802854 Slawik, 2007, Adipose tissue expandability and the metabolic syndrome, Genes Nutr, 2, 41, 10.1007/s12263-007-0014-9 Unger, 2003, Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome, Endocrinology, 144, 5159, 10.1210/en.2003-0870 Nichols, 2007, Weight changes following the initiation of new anti-hyperglycaemic therapies, Diabetes Obes Metab, 9, 96, 10.1111/j.1463-1326.2006.00580.x Miles, 2003, Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding, Am J Physiol Endocrinol Metab, 284, E618, 10.1152/ajpendo.00312.2002 Tonelli, 2004, Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes, Diabetes, 53, 1621, 10.2337/diabetes.53.6.1621 Fruhbeck, 2001, The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation, Am J Physiol Endocrinol Metab, 280, E827, 10.1152/ajpendo.2001.280.6.E827 Saltiel, 2001, You are what you secrete, Nat Med, 7, 887, 10.1038/90911 Friedman, 2002, The function of leptin in nutrition, weight, and physiology, Nutr Rev, 60, S1, 10.1301/002966402320634878 Gorden, 2003, The clinical uses of leptin, Curr Opin Pharmacol, 3, 655, 10.1016/j.coph.2003.06.006 Licinio, 2004, Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults, Proc Natl Acad Sci U S A, 101, 4531, 10.1073/pnas.0308767101 Muse, 2004, Role of resistin in diet-induced hepatic insulin resistance, J Clin Invest, 114, 232, 10.1172/JCI200421270 Rajala, 2003, Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis, Endocrinology, 144, 3765, 10.1210/en.2003-0580 Steppan, 2001, The hormone resistin links obesity to diabetes, Nature, 409, 307, 10.1038/35053000 Reitman, 2004, Magic bullets melt fat, Nat Med, 10, 581, 10.1038/nm0604-581 Jiang, 2005, Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1, J Clin Invest, 115, 1030, 10.1172/JCI200523962 Tomlinson, 2004, 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response, Endocr Rev, 25, 831, 10.1210/er.2003-0031 Bays, 2008, Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Rev Cardiovasc Ther, 6, 343, 10.1586/14779072.6.3.343 Gesta, 2007, Developmental origin of fat: tracking obesity to its source, Cell, 131, 242, 10.1016/j.cell.2007.10.004 Karagiannides, 2001, Altered expression of C/EBP family members results in decreased adipogenesis with aging, Am J Physiol Regul Integr Comp Physiol, 280, R1772, 10.1152/ajpregu.2001.280.6.R1772 Schipper, 2008, Regional anatomic and age effects on cell function of human adipose-derived stem cells, Ann Plast Surg, 60, 538, 10.1097/SAP.0b013e3181723bbe Tchkonia, 2007, Increased TNFalpha and CCAAT/enhancer- binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis, Am J Physiol Endocrinol Metab, 293, E1810, 10.1152/ajpendo.00295.2007 Dubois, 2006, Decreased expression of adipogenic genes in obese subjects with type 2 diabetes, Obesity (Silver Spring), 14, 1543, 10.1038/oby.2006.178 Vazquez-Vela, 2008, White adipose tissue as endocrine organ and its role in obesity, Arch Med Res, 39, 715, 10.1016/j.arcmed.2008.09.005 Sorisky, 2000, Adipose cell apoptosis: death in the energy depot, Int J Obes Relat Metab Disord, 24, S3, 10.1038/sj.ijo.0801491 Tan, 2004, Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans, Obes Res, 12, 114, 10.1038/oby.2004.15 Cases, 2000, The regulation of body fat distribution and the modulation of insulin action, Int J Obes Relat Metab Disord, 24, S63, 10.1038/sj.ijo.0801508 Snijder, 2003, Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study, Am J Clin Nutr, 77, 1192, 10.1093/ajcn/77.5.1192 Nielsen, 2004, Splanchnic lipolysis in human obesity, J Clin Invest, 113, 1582, 10.1172/JCI21047 Einstein, 2005, Differential responses of visceral and subcutaneous fat depots to nutrients, Diabetes, 54, 672, 10.2337/diabetes.54.3.672 Harp, 2004, New insights into inhibitors of adipogenesis, Curr Opin Lipidol, 15, 303, 10.1097/00041433-200406000-00010 Moitra, 1998, Life without white fat: a transgenic mouse, Genes Dev, 12, 3168, 10.1101/gad.12.20.3168 Shimomura, 1998, Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy, Genes Dev, 12, 3182, 10.1101/gad.12.20.3182 Barak, 1999, PPAR gamma is required for placental, cardiac, and adipose tissue development, Mol Cell, 4, 585, 10.1016/S1097-2765(00)80209-9 Rosen, 1999, PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro, Mol Cell, 4, 611, 10.1016/S1097-2765(00)80211-7 Koutnikova, 2003, Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice, Proc Natl Acad Sci U S A, 100, 14457, 10.1073/pnas.2336090100 He, 2003, Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle, Proc Natl Acad Sci U S A, 100, 15712, 10.1073/pnas.2536828100 Medina-Gomez, 2005, The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform, Diabetes, 54, 1706, 10.2337/diabetes.54.6.1706 Zhang, 2004, Selective disruption of PPAR{gamma}2 impairs the development of adipose tissue and insulin sensitivity, Proc Natl Acad Sci U S A, 101, 10703, 10.1073/pnas.0403652101 Strawford, 2004, Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O, Am J Physiol Endocrinol Metab, 286, E577, 10.1152/ajpendo.00093.2003 Neese, 2002, Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA, Proc Natl Acad Sci U S A, 99, 15345, 10.1073/pnas.232551499 Unger, 2000, Lipotoxic diseases of nonadipose tissues in obesity, Int J Obes Relat Metab Disord, 24, S28, 10.1038/sj.ijo.0801498 Virtue, 2008, It's not how fat you are, it's what you do with it that counts, PLoS Biol, 6, e237, 10.1371/journal.pbio.0060237 Medina-Gomez, 2007, Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1), Public Health Nutr, 10, 1132, 10.1017/S1368980007000614 Reitman, 1999, Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes, Ann N Y Acad Sci, 892, 289, 10.1111/j.1749-6632.1999.tb07802.x Gray, 2006, Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice, Diabetes, 55, 2669, 10.2337/db06-0389 Medina-Gomez, 2007, PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism, PLoS Genet, 3, e64, 10.1371/journal.pgen.0030064 Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J Clin Invest, 117, 2621, 10.1172/JCI31021 Balas, 2007, Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis, J Hepatol, 47, 565, 10.1016/j.jhep.2007.04.013 Belfort, 2006, A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis, N Engl J Med, 355, 2297, 10.1056/NEJMoa060326 Tiraby, 2003, Acquirement of brown fat cell features by human white adipocytes, J Biol Chem, 278, 33370, 10.1074/jbc.M305235200 Magun, 1998, Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation, Diabetes, 47, 1948, 10.2337/diabetes.47.12.1948 Xu, 2004, Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation, J Biol Chem, 279, 35914, 10.1074/jbc.M402297200 Villarroya, 2005, Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity, Trends Pharmacol Sci, 26, 88, 10.1016/j.tips.2004.12.005 Rupnick, 2002, Adipose tissue mass can be regulated through the vasculature, Proc Natl Acad Sci U S A, 99, 10730, 10.1073/pnas.162349799 Dallabrida, 2003, Adipose tissue growth and regression are regulated by angiopoietin-1, Biochem Biophys Res Commun, 311, 563, 10.1016/j.bbrc.2003.10.007 Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514 Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity- related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 Waki, 2007, Endocrine functions of adipose tissue, Annu Rev Pathol, 2, 31, 10.1146/annurev.pathol.2.010506.091859